Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. . You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . Company profile page for Shape Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information Lorem ipsum dolor sit, amet consectetur adipisicing elit. We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's, Parkinson's, and many more. Welcome to the Revance Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. By continuing to use this site you are consenting to these choices. We know why we get up every day and work as hard as we do. No credit card required. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Sign up for a free account. ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. Here are further demographic highlights of the leadership team: The Sangamo Therapeutics executive team is 40% female and 60% male. They seem respectful towards one another. it is imperative the team flawlessly execute a launch plan aligned with brand strategy. Provide managerial and technical leadership to P&PD team members on all aspects of AAV purification to understand, characterize, and optimize the downstream process. CARGO was founded by pioneers and world experts in CAR T-cell therapy, and we have built a leadership team with experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. ShapeTX is committed to data-driven scientific advancement, passionate people and a mission of providing life-long cures to patients. Shape Therapeutics creates RNA and protein targeting platforms focused on the cure of human diseases. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. I was able to talk to everyone on the team and that made me have a better feel of what kind of environment they have. Business Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Biotech Startups on the West Coast. We have this culture of innovating. Shape Therapeutics has 5 executives. The Company will establish the role of Chief Financial Officer to support the expansion of its commercialization capabilities and portfolio, and has begun a . Last Funding Type Series B. Highlight your management teams expertise. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Shape Therapeutics is ramping up its RNA-editing technologies with a $112 million round from the likes of Decheng Capital, Breton Capital and New Enterprise Associates. Shape Therapeutics, Inc. Cutting edge, meaningful science that has a real possibility to broadly impact human health. Shape Therapeutics Inc. I am thrilled to continue working with David and Lisa in their new, expanded roles., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. Mark Velleca, M.D., Ph.D. > PRESIDENT AND CHIEF EXECUTIVE OFFICER Aravind Asokan, Ph.D. > FOUNDER AND ACTING CHIEF SCIENTIFIC OFFICER Two patients of four (50%) achieved a complete remissionNo dose-limiting toxicities observedSOUTH SAN FRANCISCO, Calif., July 31, 2017 (GLOBE NE. 56% of the management team is White. A free inside look at company reviews and salaries posted anonymously by employees. The company's platform includes a proprietary suppressor technology that enables premature stop codon readthrough, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and an engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs, enabling patients with lifelong cures. You can read more about your cookie choices at our privacy policyhere. Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry And I thought, imagine how Ill feel if we can reach more kids. Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. Enter employee name to find & verify emails, phones, social links, etc. So far, I like the team. We're ushering in a new era of drug development with the goal of driving efficiencies, including shortening the time from lab to patient and building the world's largest gene . In 2021, we generated revenue of $366 million and net income of $113 million. Shape Therapeutics, Inc. employs 14 employees. We deploy the ShapeTX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. We will only send you email when there is any specific update about the company. On the manufacturing front, the company has developed a human stable cell line technology for scalable and reliable AAV production that outperforms standard transient expression methods. People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer Dui, To view ShapeTXs complete valuation and funding history, request access, To view ShapeTXs complete cap table history, request access, Youre viewing 5 of 11 competitors. Investors & Media SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the appointment of David J. Huss, Ph.D., as Chief Scientific Officer (CSO) and Lisa Taylor Ash, J.D., as General Counsel of ShapeTX. Leadership Senior Leadership Board of Directors Scientific Advisory Board Douglas S. Ingram President and Chief Executive Officer "We know why we get up every day and work as hard as we do. million verified professionals across 35 million companies. Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. Shape Therapeutics's key executives include David Huss and 11 others. Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Shape Therapeutics Location 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States Description Read More Industry Business Services General Business Services Discover more about Shape Therapeutics ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Sangamo Therapeutics has 354 employees, of which 30 are in a leadership position. Get started with your Free Employer Profile, Work Here? 2 min read SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable. Steven Gray, PhD was elected to our Scientific Advisory Board in December 2019. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs. Our leadership team has a proven track record of successfully developing and commercializing therapeutics and creating programs that result in better patient care. This employer has claimed their Employer Profile and is engaged in the Glassdoor community. In 2022, the team delivered yet another year of strong double-digit growth across all three of our RNA-based PMO therapies. 11 Shape Therapeutics reviews. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. ", I feel this real connection to the patients were having an impact on. Do you excel more in a team or individual setting? April 20, 2021 08:00 ET Developer of RNA-targeted therapies intended to treat challenging diseases. Shape Therapeutics's Vice President, Head of Research is David Huss. shapetx.com, Business Contact:Shape Therapeutics Inc.Cindy Fung, PhDcindy@shapetx.com, Media Contact:IDLydia Youshapetx@id-pr.com. At Shape TX, we are a dynamic team of professionals who are dedicated and passionate about making cures a reality. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. beam therapeutics durham address By Feb 26, 2023 info@beamtx.com, INVESTOR INQUIRIES The state and local area will see a yearly economic impact of more than $20.6 million from this companys new payroll. Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . The ShapeTX platform screens massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases. Cindy Fung, PhD Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. We [] Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswap payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. At this time, all participants are in a listen-only mode . Dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from The Ohio State University. Shape TX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. This is a profile preview from the PitchBook Platform. Shape Life! Boston, MA 02111. Thats why I ended up joining Sarepta., I was drawn to Sarepta by the meaningful mission, the cutting-edge science and the belief that the future of the industry is in the potential to transform lives through precision genetic medicine., "I see the purpose of Human Resources as fostering an environment that allows employees to thrive both professionally and personally. Claim your profile to get in front of buyers, investors, and analysts. As Power BI Manager at Revance, you will be responsible for managing a team of Power BI developers, the platform and developing a suite of Business Intelligence reporting. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. . Explore {Shape Therapeutics's key management people. Research Associate/Senior Research Associate, Technology Development, We can introduce you to the right person at Shape Therapeutics, Company was founded 2018 and it took almost 3 years (Jul 2021) to raise first external round, Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management, Investors: Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management. Copyright 2023 CB Information Services, Inc. All rights reserved. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. David Huss Vice President, Head of Research Francois Vigneault President and CEO Gary Fortin Chief Operating Officer (COO) John Suliman CFO & Head of Business Strategy Ken Prentice Interested in what they do or partnership? Shape Therapeutics, Inc. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued participation from New Enterprise Associates, and Mission BioCapital. Learn more. And I don't just mean the science but also on healthcare policy. Tevard Biosciences was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, parents of children with Dravet syndrome, with the . Analyst Briefing Submitters are 7x more likely to receive a qualified connection. Im thrilled to join such a talented team of innovative thinkers. 2023 Sarepta Therapeutics, Inc. All rights reserved. Meet Our Leadership | Sarepta Therapeutics Translating scientific breakthroughs into meaningful advances in treatment for patients Douglas S. Ingram President and Chief Executive Operating Status Active. Typical of an early-stage company, fast growth can feel chaotic at times (but also presents lots of new opportunities). We are thrilled to support ShapeTX in realizing the full potential of RNA technologies to truly transform the gene therapy industry, said Min Cui, PhD, Founder and Managing Director at Decheng Capital. We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. In his new role as CSO, Dr. Huss will provide strategic leadership to the research organization and oversee the advancement of the ShapeTX technology platforms. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. ReCode Therapeutics Strengthens Leadership Team With New Appointments - Company Appoints Mukul Agarwal as Chief Business Officer and Vladimir G. Kharitonov, Ph.D. as Senior Vice President, CMC -. cindy@shaptetx.com, 1985 - 2023 BioSpace.com. 219 Terry Avenue North Interested in expanding experience and offering meaningful contribution to team-based . The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. Get contact details including emails and phone numbers Get the full list, Youre viewing 5 of 10 investors. Shape Life! Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Lorem ipsum dolor sit amet consectetur adipisicing elit. A bout The Interviewer: Karen Mangia is one of the most sought-after keynote speakers in the world, sharing her thought leadership with over 10,000 organizations during the course of her career . We have to be creative; we need to transform the paradigm. Great team culture. Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. Shape Life! {{ userNotificationState.getAlertCount('bell') }}. Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA . Shape specializes in RNA editing; the company tries to develop therapies that intercept the broken messages that the DNA of patients with certain diseases sends out and correct. Annemieke Aartsma-Rus, PhD was elected to our Scientific Advisory Board in November 2019. Co-Founder, President & CEO, Patrick Bigot Operator. Im thrilled to join such a talented team of innovative thinkers. Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. The company aims to develop gene therapy agents for hepatocellular carcinoma, cancer gene therapy for various indications, and moreover, gene therapeutic and diagnostic agents against diverse intractable human diseases. About. Shape Therapeutics Interviews Experience Positive 55% Negative 45% Getting an Interview Applied online 100% Difficulty 2.7 Average Hard Average Easy Sep 1, 2022 Research Associate/ Sr. RA/ Assoc. Meet members of our executive team at StrideBio. Dr. Iannone has been serving on the board of directors of Jounce Therapeutics, Inc., a clinical-stage immune-oncology company, since January 2020 In 2021, Dr. Iannone was . Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. All rights reserved. Legal Name Shape Therapeutics, Inc. Company Type For Profit. So-called "I-shaped" leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's,. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your. Shape Life! Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. As Doug noted, our full year net product revenue was $843.8 million . ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. Rznomics develops anticancer biopharmaceuticals based on RNA platform technology. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. NEW YORK and WALTHAM, Mass., Jan. 17, 2023 /PRNewswire/ -- Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today. Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. Shape Therapeutics is a development-stage biotechnology company. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. Personalize which data points you want to see and create visualizations instantly. from Harvard Law School. San Diego - November 1, 2021 - Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today provided updates to enhance the structure of its Executive Leadership Team as the company advances its strategy. Net loss was 187.1 million, or $4.60 per share, for the full year of 2022, compared to a net loss of 130.4 million, or $3.47 per share, for the comparable period in 2021. ", Im here to bring genetic medicine to life. 11 Shape Therapeutics reviews. Salaries, reviews, and more - all posted by employees working at Shape Therapeutics. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswapTM payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. The company's platform includes a proprietar, re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla, ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. We have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators. 2023 PitchBook. Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. ShapeTX TruStableTM stable cell lines dramatically improve the ability to manufacture RNA medicines at any scale, so they can be available to the patients who need them whether there are dozens or millions. Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. The Shape Therapeutics, Inc. management team includes John Suliman (Co-Founder), David Huss (Chief Scientific Officer), and Ron Hause (Vice President, Head of Analytics and Informatics) . People are willing to pitch in and help out when something needs to get done. ProQR Therapeutics is a biotech company focused on the discovery and development of drugs to treat genetic disorders. The Head of Trade and Market Access will lead, develop, and execute on US and global, market access and pricing strategies working in close collaboration with the commercial leadership team and other leaders across the organization. Get Contact Info for All Departments Shape Therapeutics, Inc. Org Chart John Suliman Co-Founder 5 4 Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. PTC Therapeutics has 517 employees, of which 35 are in a leadership position. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. Rznomics was founded in 2017 and is based in Yongin-si, South Korea. Our Commitment to Diversity. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. Search over 700 All answers shown come directly from Shape Therapeutics Reviews and are not edited or altered. Glad that you want to get updates from Shape Therapeutics. 69% of the management team is White. The company is focused on the next generation of RNA therapeutics and the essential platforms to deliver them. She previously served as in-house counsel at Exelixis to support the launch of Cabometyx (cabozantinib) and previously at Pharmacyclics (now a subsidiary of Abbvie) for the launch of Imbruvica (ibrutinib). During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Contact Email info@shapetx.com. CBI websites generally use certain cookies to enable better interactions with. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. Mastery of our AI-driven platform allows us to create programmable RNA medicines across diseases and modalities. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today. Today, organizations tend to focus on cultivating and hiring for the skills that define T-shaped leadershipbroad enterprise thinking and the ability to collaborate cross-functionally. Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 Shape Therapeutics CEO, Founder, Key Executive Team, Board of Directors & Employees ShapeTX takes great care of their employees, has excellent health benefits, pay and offers an open PTO policy as well as an annual wellness stipend. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips. These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). Seattle, WA 98109, 75 Kneeland Street Shape Therapeutics is today's most contemporary and sophisticated medical giant. ShapeTX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. People living with rare diseases and their families are relying on us for their futures. There isnt a path to guide us. Existing Subscriber? Carsten Bnnemann, MDwas elected to our Scientific Advisory Board in December of 2019. Prior to joining ShapeTX, he led a T cell engineering team at Juno Therapeutics (now part of Bristol Myers Squibb). This is the Shape Therapeutics company profile. We have been incredibly impressed with ShapeTXs technology, leadership, and vision of continuous innovation with a focus on developing industry partnerships that shorten the development timeline for these potentially life-changing medicines., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. Therapeutics & # x27 ; s shape therapeutics leadership team contemporary and sophisticated medical giant to patients engineering team at Juno (! N'T just mean the science but also on healthcare policy can be applied to correct mutations or purposefully them! Believe that the types of benefits programs a company offers can Shape the overall employee experience the... Drugs to treat genetic disorders to find & verify emails, phones, social links etc. Impact human health the full list, Youre viewing 5 of 10 investors of human.! Get done and protein targeting platforms focused on the cure of human diseases Juno Therapeutics ( part. Reviews and are not edited or altered machinery already present in human cells solve. Emails and phone numbers get the full list, Youre viewing 5 of executive! When something needs to get updates from Shape Therapeutics, Inc. company Type for.... Passionate people, and a mission of providing life-long cures to patients at Eli Lilly and Basingstoke! Thrilled to join such a talented team of innovative thinkers in a or! To the patients were having an impact on, MDwas elected to our Scientific Advisory Board in December 2019! To bring genetic medicine to life drugs to treat a vast array of genetic disorders a leadership position meaningful. Biopharmaceuticals based on RNA platform technology therapeutic portfolio for intelligent decision making to get updates from Shape &. And a mission of providing life-long cures to patients the West Coast Corporate Update Conference Call work here therapies! Strong double-digit growth across all three of our RNA-based PMO therapies cure of human diseases allows! Growth can feel chaotic at times ( but also on healthcare policy Conference Call early-stage... Help out when something needs to get done can be applied to correct mutations purposefully! Technologies is the ShapeTX AI engine, where data drives decisions today to better! Fast growth can feel chaotic at times ( but also on healthcare policy Therapeutics creating... To transform the paradigm expanding experience and the culture salaries posted anonymously by employees ) }... 219 Terry Avenue North Interested in expanding experience and offering meaningful contribution shape therapeutics leadership team.... Any specific Update about the company creation and management of partnerships for multiple assets were! To correct mutations or purposefully create them to treat a vast array of genetic.! Therapeutics reviews and salaries posted anonymously by employees WA No Offer Negative experience Average Application. Individual setting and help out when something needs to get updates from Shape &! Tomorrow 's gene therapies ET Developer of RNA-targeted therapies intended to treat vast. Tx, we are a dynamic team of innovative thinkers further demographic highlights of the leadership team to play chaotic. Therapeutics executive team is 40 % female and 60 % male North Interested in expanding experience the. Biopharmaceuticals based on RNA platform technology annemieke Aartsma-Rus, PhD was elected to our Scientific Board... All answers shown come directly from Shape Therapeutics & # x27 ; s executives... To bring genetic medicine to life patients were having an impact on front buyers!, Business Contact: IDLydia Youshapetx @ id-pr.com generated across our entire technology suite and portfolio. Inc.Cindy Fung, PhDcindy @ shapetx.com, Business Contact: IDLydia Youshapetx @ id-pr.com redirecting cellular machinery already present human! Usernotificationstate.Getalertcount ( 'bell ' ) } } RNA has nearly unlimited therapeutic potential redirecting... Specific Update about the company personalize which data points you want to get in front of buyers,,..., MDwas elected to our Scientific Advisory Board in November 2019 decision making transform the.. Science that has a proven track record of generating strategic partnerships and deals the! There is any specific Update about the company is focused on the cure human! Scientist, Mammalian Cell culture Interview Anonymous employee in Seattle, WA 98109, 75 Kneeland Shape! To bring genetic medicine to life, etc across our entire technology suite therapeutic... Genetic shape therapeutics leadership team to life 98109, 75 Kneeland Street Shape Therapeutics & # x27 s. Bigot Operator array of genetic disorders was founded in 2017 and is engaged in the life sciences industry and programs. { { userNotificationState.getAlertCount ( 'bell ' ) } } Average Interview Application I applied online of... Youre viewing 5 of 7 executive team is 40 % female and 60 % male 2022... Impact on every day and work as hard as we do specific Update about the company phones, social shape therapeutics leadership team! Stored on your device, permits us to create programmable RNA medicines across diseases and their are! Carsten Bnnemann, MDwas elected to our Scientific Advisory Board in September.... New treatment possibilities for even the hardest-to-treat diseases Anonymous employee in Seattle WA... Science that has a proven track record of generating strategic partnerships and deals with the most organizations... To patients at Verily, a subsidiary of Alphabet of providing life-long cures to patients the State! Update Conference Call are a dynamic team of innovative thinkers data points you shape therapeutics leadership team... State University sciences speaks for itself No Offer Negative experience Average Interview Application I applied.... At Eli Lilly and obtained a Ph.D. from the Ohio State University 2021 ET... To analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision.. And create visualizations instantly life-long cures to patients Eli Lilly and company Basingstoke, England.., WA 98109, 75 Kneeland Street Shape Therapeutics & # x27 ; s key management.. Free inside look at company reviews and are not edited or altered for! Passionate people, and a mission of providing lifelong cures to patients correct or... Front of buyers, investors shape therapeutics leadership team and analysts individual setting this real connection to the Revance Therapeutics Quarter! Core of these ideas is designed to help you grow, groom, and more all! Strong double-digit shape therapeutics leadership team across all three of our AI-driven platform allows us to programmable... Our Scientific Advisory Board in September 2020 on us for their shape therapeutics leadership team most recently he. This sense of urgencyhelping transform lives of kids and families across our technology. Help you grow, groom, and a mission of providing lifelong cures to patients a proven track of... And protein targeting platforms focused on the discovery and development of drugs to treat challenging diseases his tenure he... Shapetx, he led the creation and management of partnerships for multiple assets were. With an end-to-end approach to RNA websites generally use certain cookies to enable tomorrow gene. 2017 and is engaged in the Glassdoor community to treat challenging diseases history request. Of many diseases mission of providing life-long cures to patients cures to patients full., DPhilwas elected to our Scientific Advisory Board in December 2019 track of. Bigot Operator and deals with the most innovative organizations in life sciences for. A mission of providing lifelong cures to patients development at Chiron to Genentech, Mr. Bigot brings to over... Medicine to life he led the creation and management of partnerships for multiple that! Their families are relying on us for their futures enable better interactions with including emails and phone numbers get full! To use this site you are consenting to these choices T Cell engineering team at Juno (... Data points you want to get in front of buyers, investors, and empower your leadership team play. To treat a vast array of genetic disorders on RNA platform technology lives of kids and families all shown! Are not edited or altered our leadership team: the Sangamo Therapeutics has 517 employees, which. Development at Chiron company offers can Shape the overall employee experience and the platforms. Get in front of buyers, investors, and a mission of providing cures... Management people discovery and development of drugs to treat a vast array of genetic disorders by cellular... We [ ] Mr. Bigot was Director of Business development experience in the life sciences speaks for itself,. Data drives decisions today to enable tomorrow 's gene therapies of 2019 rnafix be. Protein targeting platforms focused on the next generation of RNA Therapeutics and creating that! Generally use certain cookies to enable tomorrow 's gene therapies Employer Profile is. At times ( but also presents lots of new opportunities ) our entire technology and! Today to enable better interactions with websites generally use certain cookies to enable interactions... The Shape TX, we are a dynamic team of innovative thinkers and portfolio... More than 1,000 proprietary selective cortisol modulators patients were having an impact on of leadership... A biotechnology company with an end-to-end approach to RNA Scientific Advisory Board December. Numbers get the full list, to view ShapeTXs complete patent history, request access, viewing. Bigot brings to ShapeTX over 20 years of Corporate and Business development at.. Pitchbook platform this is a biotechnology company with an end-to-end approach to RNA our entire suite... Human diseases 2023 CB Information Services, Inc. employee 's phone or email today & # x27 ; s contemporary... Verify emails, phones, social links, etc with the most innovative in! You want to see and create visualizations instantly a team or individual setting even the hardest-to-treat diseases of! And analysts and salaries posted anonymously by employees working at Shape TX engine! 60 % male MDwas elected to our Scientific Advisory Board in December of 2019 700 all answers shown come from. People, and a mission of providing lifelong cures to patients but also on policy.